“-Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic version of NAMENDA® (memantine HCl) tablets in the US market on July 12, 2015, approved by the United States Food & Drug Administrati
“-Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic version of NAMENDA® (memantine HCl) tablets in the US market on July 12, 2015, approved by the United States Food & Drug Administrati
このブックマークにはスターがありません。
最初のスターをつけてみよう！
Dr. Reddy’s Announces the Launch of MEMANTINE HYDROCHLORIDE TABLETS, USP
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／